Each of the clinics that make up IVI RMA's worldwide network (more than 65 clinics) is likely to pursue one or more of the lines of...
A total of 37 winners were selected for the first edition of the Business Plan Competition (CPA) out of a thousand candidates in the thirteen regions...
The Catalan pharmaceutical company Grifols reduced its profit by 46% through June, a period in which it earned €144.1 million. In 2021, the pharmaceutical company specializing...
Nexi ended the first half of the year with €1.52 billion in revenues (+8.7%) and Ebitda of an impressive €702.4 million (+19.1%), against net financial debt...
After the Komsilga power plant, Minister Maminata Traoré/Coulibaly completed her visit to the Zagtouli site, which houses the country's largest solar power plant. It was built...
Novartis has the worst rating in the European pharmaceutical industry, while AstraZeneca downgrades its expectations from exceptional to neutral. Credit Suisse has also analyzed the Spanish...
The Berlin based company Moss would not be the first fintech company to emancipate itself in this way. Just at the end of August, Berlin-based neobank...
The concessionaire group of the Lobito Corridor is establishing contact with the authorities of the Democratic Republic of Congo (DRC) and with the National Society of...
Indukern is a national business group created in 1962. Its activity is focused on human and animal health through its two main companies: Kern Pharma, a...
The fintech market could see a notable slowdown in activity, especially compared to the high peaks of 2021. While investment in fintech companies is expected to...